FDA recall D-0631-2018

Sandoz Incorporated · Class III · drug

Product

Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC 0781-5067-05.

Reason for recall

Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).

Distribution

Nationwide in the USA and Puerto Rico

Key facts

Status
Terminated
Initiation date
2018-04-06
Report date
2018-04-25
Termination date
2019-04-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Broomfield, CO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0631-2018